ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Investigational phosphodiesterase inhibitors in phase I and phase II clinical trials for Alzheimer’s disease
Expert Opinion on Investigational Drugs
◽
10.1080/13543784.2017.1364360
◽
2017
◽
Vol 26
(9)
◽
pp. 1033-1048
◽
Cited By ~ 63
Author(s):
Jos Prickaerts
◽
Pim R. A. Heckman
◽
Arjan Blokland
Keyword(s):
Alzheimer’S Disease
◽
Alzheimer's Disease
◽
Clinical Trials
◽
Phase I
◽
Phase Ii
◽
Phosphodiesterase Inhibitors
◽
Phase Ii Clinical Trials
Download Full-text
Related Documents
Cited By
References
Beta-secretase inhibitors in phase I and phase II clinical trials for Alzheimer’s disease
Expert Opinion on Investigational Drugs
◽
10.1080/13543784.2017.1369527
◽
2017
◽
Vol 26
(10)
◽
pp. 1131-1136
◽
Cited By ~ 26
Author(s):
Charbel E-H. Moussa
Keyword(s):
Alzheimer’S Disease
◽
Alzheimer's Disease
◽
Clinical Trials
◽
Phase I
◽
Phase Ii
◽
Phase Ii Clinical Trials
◽
Beta Secretase
Download Full-text
Improving Alzheimer's disease phase II clinical trials
Alzheimer s & Dementia
◽
10.1016/j.jalz.2012.02.002
◽
2012
◽
Vol 9
(1)
◽
pp. 39-49
◽
Cited By ~ 18
Author(s):
Barry D. Greenberg
◽
Maria C. Carrillo
◽
J. Michael Ryan
◽
Michael Gold
◽
Kim Gallagher
◽
...
Keyword(s):
Alzheimer’S Disease
◽
Alzheimer's Disease
◽
Clinical Trials
◽
Phase Ii
◽
Phase Ii Clinical Trials
Download Full-text
CTLA4 antagonists in phase I and phase II clinical trials, current status and future perspectives for cancer therapy
Expert Opinion on Investigational Drugs
◽
10.1080/13543784.2019.1559297
◽
2018
◽
Vol 28
(2)
◽
pp. 149-159
◽
Cited By ~ 11
Author(s):
Bartosz Szostak
◽
Filip Machaj
◽
Jakub Rosik
◽
Andrzej Pawlik
Keyword(s):
Clinical Trials
◽
Cancer Therapy
◽
Phase I
◽
Phase Ii
◽
Current Status
◽
Future Perspectives
◽
Phase Ii Clinical Trials
Download Full-text
Investigational drug therapies in phase I and phase II clinical trials for alcohol use disorders
Expert Opinion on Investigational Drugs
◽
10.1080/13543784.2018.1502269
◽
2018
◽
Vol 27
(8)
◽
pp. 677-690
◽
Cited By ~ 3
Author(s):
Leigh C Walker
◽
Andrew J Lawrence
Keyword(s):
Clinical Trials
◽
Alcohol Use
◽
Phase I
◽
Phase Ii
◽
Alcohol Use Disorders
◽
Investigational Drug
◽
Phase Ii Clinical Trials
Download Full-text
Phase I and phase II clinical trials in sarcoma: Implications for drug discovery and development
Cancer Medicine
◽
10.1002/cam4.1958
◽
2019
◽
Vol 8
(2)
◽
pp. 585-592
◽
Cited By ~ 2
Author(s):
Daniel Y. Lee
◽
Arthur P. Staddon
◽
Jacob E. Shabason
◽
Ronnie Sebro
Keyword(s):
Clinical Trials
◽
Drug Discovery
◽
Phase I
◽
Phase Ii
◽
Drug Discovery And Development
◽
Phase Ii Clinical Trials
Download Full-text
PHASE I AND PRELIMINARY PHASE II CLINICAL TRIALS OF BESTATIN
Small Molecular Immunomodifiers of Microbial Origin
◽
10.1016/b978-0-08-027993-0.50015-1
◽
1981
◽
pp. 159-172
◽
Cited By ~ 1
Author(s):
Hisashi MAJIMA
Keyword(s):
Clinical Trials
◽
Phase I
◽
Phase Ii
◽
Phase Ii Clinical Trials
◽
Preliminary Phase
Download Full-text
Abstract 3809: Evaluation of the novel, orally bioavailable selective inhibitor of nuclear export (SINE) KPT-335 (verdinexor) in spontaneous canine cancer: Results of phase I and phase II clinical trials
10.1158/1538-7445.am2014-3809
◽
2014
◽
Cited By ~ 1
Author(s):
Cheryl A. London
◽
Luis Feo Bernabe
◽
Sandra Barnard
◽
William Kisseberth
◽
Antonella Borgatti
◽
...
Keyword(s):
Clinical Trials
◽
Phase I
◽
Phase Ii
◽
Nuclear Export
◽
Selective Inhibitor
◽
The Novel
◽
Phase Ii Clinical Trials
◽
Canine Cancer
◽
Orally Bioavailable
Download Full-text
P3-009: Study Design and Characteristics of Two Phase II Proof-of-Concept Clinical Trials of the PDE9 Inhibitor BI 409306 in Early Alzheimer's Disease
Alzheimer s & Dementia
◽
10.1016/j.jalz.2016.06.1666
◽
2016
◽
Vol 12
◽
pp. P820-P821
◽
Cited By ~ 4
Author(s):
Glen Wunderlich
◽
Claus Thamer
◽
Michael Roehrle
◽
Miguel Garcia
◽
Lutz Frölich
◽
...
Keyword(s):
Alzheimer’S Disease
◽
Alzheimer's Disease
◽
Clinical Trials
◽
Phase Ii
◽
Study Design
◽
Proof Of Concept
◽
Two Phase
◽
Early Alzheimer’S Disease
Download Full-text
Promising investigational drug candidates in phase I and phase II clinical trials for mesothelioma
Expert Opinion on Investigational Drugs
◽
10.1080/13543784.2017.1351545
◽
2017
◽
Vol 26
(8)
◽
pp. 933-944
◽
Cited By ~ 7
Author(s):
Alice Guazzelli
◽
Emyr Bakker
◽
Kun Tian
◽
Constantinos Demonacos
◽
Marija Krstic-Demonacos
◽
...
Keyword(s):
Clinical Trials
◽
Phase I
◽
Phase Ii
◽
Investigational Drug
◽
Drug Candidates
◽
Phase Ii Clinical Trials
Download Full-text
Nursing, morality, and emotions: Phase I and phase II clinical trials and patients with cancer
Cancer Nursing
◽
10.1097/00002820-199908000-00001
◽
1999
◽
Vol 22
(4)
◽
pp. 251-259
◽
Cited By ~ 20
Author(s):
Meinir Krishnasamy
Keyword(s):
Clinical Trials
◽
Phase I
◽
Phase Ii
◽
Patients With Cancer
◽
Phase Ii Clinical Trials
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close